| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |